Meloxicam in acute episodes of soft-tissue rheumatism of the shoulder

Inflammation Research

Volumn 50, Issue SUPPL. 1, 2001, Pages

  Vidal, L ^a   Kneer, W ^b   Baturone, M ^c   Sigmund, R ^d  

^a Boehringer Ingelheim Peru   (Peru)

^b Hospital Vigil de Quiñones ^*  (Germany)

^c Hospital Vigil de Quinones   (Spain)

^d BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Meloxicam; Nonsteroidal anti inflammatory drugs; Rheumatoid arthritis

Indexed keywords

MELOXICAM; PIROXICAM;

ACUTE DISEASE; ADULT; ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NONARTICULAR RHEUMATISM; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SHOULDER PAIN; SIDE EFFECT; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; CYCLOOXYGENASE INHIBITORS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PIROXICAM; SHOULDER PAIN; THIAZINES; THIAZOLES;

EID: 0035078507     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. The range of movement of the shoulder joint at various ages
2. The long-term course of shoulder complaints: A prospective study in general practice
3. The use of radiographs to evaluate shoulder pain in the ED
4. Comparison of magnetic resonance imaging and arthroscopy in the evaluation of shoulder pathology
5. Diagnostic and therapeutic impact of MRI and arthrography in the investigation of full-thickness rotator cuff tears
6. Axillary projection in radiography of the nontraumatized shoulder
7. Introduction of a new physical examination procedure for the differentiation of acromioclavicular joint lesions and subacromial impingement
8. Double-blind comparison of piroxicam and indomethacin in the treatment of cervicobrachial syndrome and periarthritis scapulohumeralis (stiff shoulder)
9. A double blind, placebo controlled study of piroxicam in the management of acute musculoskeletal disorders
10. Piroxicam versus naproxen in the treatment of painful shoulder
11. Piroxicam in acute musculoskeletal disorders and sports injuries
12. Piroxicam versus naproxen in the treatment of acute musculoskeletal disorders in athletes
13. Clinical experience with cyclooxygenase-2 inhibitors
14. A review of the clinical pharmacokinetics of meloxicam
15. Meloxicam in osteoarthritis: A 6-month, double-blind comparison with diclofenac sodium
16. Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: Results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis
17. A six-month double-blind trial to compare the efficacy and safety of meloxicam 7.5 mg daily and naproxen 750 mg daily in patients with rheumatoid arthritis
18. Efficacy and safety of meloxicam in patients with rheumatoid arthritis
19. Ankrylosing spondylitis: What is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal antiinflammatory drug trial
20. Comparison of the onset and intensity of action of intramuscular meloxicam and oral meloxicam in patients with acute sciatica
21. Efficacy and tolerability of intramuscular and oral meloxicam in patients with acute lumbago: A comparison with intramuscular and oral piroxicam
22. Safety of meloxicam: A global analysis of clinical trials
23. Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients
24. Gastrointestinal safety profile of meloxicam: A meta-analysis and systematic review of randomized controlled trials
25. Impingement lesions
26. A standardised method for the assessment of shoulder function
27. Treatment of tendinitis and bursitis: A comparison of nimesulide and naproxen sodium in a double-blind parallel trial